BROWSE BY
0
Ironwood Pharmaceuticals, Inc. Banner Image

Ironwood Pharmaceuticals, Inc.

  • Ticker IRWD
    Exchange NASDAQ More
  • Industry Drugs - Generic More
  • Sector Healthcare More
Ironwood Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Cambridge, Massachusetts
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in…More the United States and Constella name in the European Union.
Visit website
REPORT RATINGS
4.8 / 5.0 (281)

Ironwood Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 281 reviews.

Ironwood Pharmaceuticals, Inc.

Most Recent Annual Report

Ironwood Pharmaceuticals, Inc.
MOST RECENT 2023 Annual Report and Form 10K
View PDF View Form 10K (HTML)

Ironwood Pharmaceuticals, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

View 2023 Environmental, Social and Governance Report

This company has a Environmental, Social and Governance Report available to view on our partner site, ResponsibilityReports.com

Older/Archived Annual Reports

Show 11 older reports
x
Ironwood Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!